ArticleCirculation research2015
How an artery heals.
Abstract readEditorialComment
In one paragraph
Article in Circulation research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Anti-inflammatory agents in atherosclerosis-and a need for reform: Extraordinary claims require extraordinary evidence.Journal of internal medicine · 2026Article
- Inflammation in atherosclerosis: a Big Idea that has underperformed so far.Current opinion in lipidology · 2025Review
- Changes in apolipoproteins following ingestion of a beverage deliveringFrontiers in nutrition · 2025Article
- Atherosclerosis: from lipid-lowering and anti-inflammatory therapies to targeting arterial retention of ApoB-containing lipoproteins.Frontiers in immunology · 2025Review
- Apolipoprotein B - An ideal biomarker for atherosclerosis?Indian heart journal · 2024Review
- Genetic or therapeutic neutralization of ALK1 reduces LDL transcytosis and atherosclerosis in mice.Nature cardiovascular research · 2023Article
- Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel.European heart journal · 2020 · on this mapArticle
- Article
- Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life.Journal of the American Heart Association · 2018Review
- Suppression of Hepatic FLOT1 (Flotillin-1) by Type 2 Diabetes Mellitus Impairs the Disposal of Remnant Lipoproteins via Syndecan-1.Arteriosclerosis, thrombosis, and vascular biology · 2018Article
Corrections and comments
- Comment on
Authors and funding
3 authors.
Kevin Jon WilliamsFrom the Section of Endocrinology, Diabetes, & Metabolism, Temple University School of Medicine, Philadelphia, PA (K.J.W.); Department of Molecular and Clinical Medicine, Sahlgrenska Academy of the University of Gothenburg, Göteborg, Sweden (K.J.W.); Departments of Medicine, Pathology & Cell Biology, and Physiology, Columbia University Medical Center, New York, NY (I.T.); and Department of Medicine (Cardiology), the Marc and Ruti Bell Program in Vascular Biology and The Center for the Prevention of Cardiovascular Disease, NYU School of Medicine, New York, NY (E.A.F.). kjwilliams@temple.edu Kevin-Jon.Williams@wlab.gu.se.
Ira TabasFrom the Section of Endocrinology, Diabetes, & Metabolism, Temple University School of Medicine, Philadelphia, PA (K.J.W.); Department of Molecular and Clinical Medicine, Sahlgrenska Academy of the University of Gothenburg, Göteborg, Sweden (K.J.W.); Departments of Medicine, Pathology & Cell Biology, and Physiology, Columbia University Medical Center, New York, NY (I.T.); and Department of Medicine (Cardiology), the Marc and Ruti Bell Program in Vascular Biology and The Center for the Prevention of Cardiovascular Disease, NYU School of Medicine, New York, NY (E.A.F.).
Edward A FisherFrom the Section of Endocrinology, Diabetes, & Metabolism, Temple University School of Medicine, Philadelphia, PA (K.J.W.); Department of Molecular and Clinical Medicine, Sahlgrenska Academy of the University of Gothenburg, Göteborg, Sweden (K.J.W.); Departments of Medicine, Pathology & Cell Biology, and Physiology, Columbia University Medical Center, New York, NY (I.T.); and Department of Medicine (Cardiology), the Marc and Ruti Bell Program in Vascular Biology and The Center for the Prevention of Cardiovascular Disease, NYU School of Medicine, New York, NY (E.A.F.).
Funding
Regression of Atherosclerosis CoreP01HL098055 · NHLBI · CLEVELAND CLINIC LERNER COM-CWRU · PI DIDONATO, JOSEPH · 2010 to 2014
$12.1MMolecular Regulation of Atherosclerosis Regression - RenewalR01HL084312 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A · 2006 to 2024
$11.4MThe Unfolded Protein Response in Sterol CytoxicityR01HL075662 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TABAS, IRA A · 2004 to 2017
$5.6MRegulation of LXR alpha by glucose & cholesterol in diabetes & atherosclerosisR01HL117226 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI FISHER, EDWARD A, GARABEDIAN, MICHAEL J. · 2014 to 2017
$2.1MMechanisms of Defective Efferocytosis in AtherosclerosisR01HL107497 · NHLBI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI TABAS, IRA A · 2012 to 2015
$1.6MLIPOPROTEIN LIPASE AND ATHEROGENESISR01HL038956 · NHLBI · THOMAS JEFFERSON UNIVERSITY · PI WILLIAMS, KEVIN JON · 1994 to 1998
–METABOLISM OF A SYNTHETIC ANTI-ATHEROGENIC LIPOPROTEINR29HL038956 · NHLBI · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI WILLIAMS, KEVIN JON · 1987 to 1991
–NHLBI NIH HHS HL075662NHLBI NIH HHS HL084312NHLBI NIH HHS HL107497NHLBI NIH HHS HL38956NHLBI NIH HHS P01 HL098055NHLBI NIH HHS R01 HL075662NHLBI NIH HHS R01 HL084312NHLBI NIH HHS R01 HL107497NHLBI NIH HHS R01 HL117226
Abstract
PubMed holds no abstract for this paper.
Indexed as
AnimalsAortaAortic DiseasesApolipoproteins BAtherosclerosisFemaleHumansLipoproteins, LDLMaleOligonucleotides, AntisenseApolipoproteins BLipoproteins, LDLOligonucleotides, AntisenseatherosclerosisEditorialendothelial functionlipids and lipoproteinslow-density lipoproteinmacrophage
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.